Alira Health Expands Its Global Clinical and Data Capabilities Through the Acquisition of CROS NT

CROS NT’s expertise in biometrics and clinical operations in Europe enhances Alira Health’s lifecycle of healthcare advisory services.

News
Category:
Published on:
June 8, 2021

FRAMINGHAM, Mass.–(BUSINESS WIRE)– Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory services firm, announced that it has acquired CROS NT (www.crosnt.com), a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT provides high quality, cost-effective biometrics and innovative solutions to help clients develop and deliver therapeutics and diagnostics that improve patient lives around the world. This acquisition brings additional expertise to Alira Health’s full spectrum of advisory and implementation services that help providers, payers and suppliers uncover opportunity, accelerate innovation, and improve outcomes for patients.

“We are extremely pleased to acquire CROS NT’s Biometrics services globally. The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said Gabriele Brambilla, Chief Executive Officer at Alira Health. “The addition of CROS NT will also enable Alira Health to expand our direct clinical operations in Europe. We embrace CROS NT’s commitment and passion to being a visionary in clinical research and are proud to welcome CROS NT CEO, Paolo Morelli, and his team to our fast-growing company.”

“CROS NT is delighted to join Alira Health to better serve our clients by providing a complete portfolio of services and solutions. We are excited to contribute to Alira Health’s mission of healthcare transformation, creating value for patients,” said Paolo Morelli, CEO of CROS NT. “Our experienced team of professionals will deliver value through our combined services, accelerating innovation and delivering tomorrow’s standard of care to patients.”

Paolo Morelli will join Alira Health’s leadership as Executive Vice President, Biometrics, and will lead the growth of Alira Health’s Data Science services.

About CROS NT:

CROS NT is a global biometrics service provider with 28+ years of experience in business, focused on clinical and observational trials. In addition, we support our clients with a full-service clinical offering delivered through a network of trusted partners.

CROS NT has offices in Bologna and Verona, Italy; London, England; Chapel Hill, NC, U.S.

 

 

To learn more about Alira Health

Contact us

Related news

Clinical Digital Health MedTech Pharma
News November 16, 2021
Alira Health Further Expands its Digital Healthcare Platform with the Acquisition of Patchai
We acquired Patchai, a digital health technology company headquartered in Italy. Patchai offers intelligent digital health solutions that engage and empower patients in clinical research(...)
Clinical Digital Health MedTech Pharma
News October 28, 2021
Alira Health Acquires BEPATIENT, A Step Forward in Humanizing Healthcare
We acquired BEPATIENT, a European healthcare technology company. BEPATIENT offers ‘real life’ digital patient data capture solutions for large pharmaceutical manufacturers, medical(...)
Clinical
Events October 22, 2021
Event: OCT Nordics 2021
Meet us at OCT Nordics October 26- 27, 2021.
Clinical
Events October 22, 2021
Event: OCT New England
Meet us at Outsourcing in Clinical Trials New England.
Clinical
Publications October 7, 2021
Tips for Successful Sponsor and CRO Collaboration
The relationship between Sponsor and CRO is a critical aspect of an effective and timely clinical trial; when the relationship is transparent and smooth, the benefit is seen by all parties.
Clinical
Multimedia June 4, 2021
Managing Relationships Between CROs and Clinical Trial Sites
Join us in this special episode of Alira Health’s Transformation Talks with a full cast of Alira Health experts.
Clinical
Publications April 6, 2021
Unlocking the Database Lock Process
In our latest whitepaper, in collaboration with CROS NT, Alira Health’s Vice President Clinical Development, Christopher Rao and Amanda Cross, US Country Manager Executive Director,(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.